BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 27006950)

  • 1. Liver Stiffness Measurement in Psoriasis: Do Metabolic or Disease Factors Play the Important Role?
    Pongpit J; Porntharukchareon S; Kaewduang P; Promson K; Stitchantrakul W; Petraksa S; Thakkinstian A; Kositchaiwat C; Rajatanavin N; Sobhonslidsuk A
    Biomed Res Int; 2016; 2016():7963972. PubMed ID: 27006950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-alcoholic fatty liver disease (NAFLD) and significant hepatic fibrosis defined by non-invasive assessment in patients with type 2 diabetes.
    Sobhonslidsuk A; Pulsombat A; Kaewdoung P; Petraksa S
    Asian Pac J Cancer Prev; 2015; 16(5):1789-94. PubMed ID: 25773826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obesity is more closely related with hepatic steatosis and fibrosis measured by transient elastography than metabolic health status.
    Huh JH; Kim KJ; Kim SU; Han SH; Han KH; Cha BS; Chung CH; Lee BW
    Metabolism; 2017 Jan; 66():23-31. PubMed ID: 27923446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic syndrome, non-alcoholic fatty liver disease and liver stiffness in psoriatic arthritis and psoriasis patients.
    Ortolan A; Lorenzin M; Tadiotto G; Russo FP; Oliviero F; Felicetti M; D'Incà R; Favero M; Piaserico S; Doria A; Ramonda R
    Clin Rheumatol; 2019 Oct; 38(10):2843-2850. PubMed ID: 31254236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and Predictors of Significant Fibrosis Among Subjects with Transient Elastography-Defined Nonalcoholic Fatty Liver Disease.
    Lee HW; Kim BK; Kim SU; Park JY; Kim DY; Ahn SH; Kim KJ; Han KH
    Dig Dis Sci; 2017 Aug; 62(8):2150-2158. PubMed ID: 28523578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus using transient elastography.
    Lai LL; Wan Yusoff WNI; Vethakkan SR; Nik Mustapha NR; Mahadeva S; Chan WK
    J Gastroenterol Hepatol; 2019 Aug; 34(8):1396-1403. PubMed ID: 30551263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transient elastography as a screening tool for liver fibrosis in a large hemodialysis population.
    Cheng BC; Yen YH; Chen JF; Wu CK; Chang KC; Tseng PL; Tsai MC; Lin MT; Lin JT; Chen JB; Hu TH
    Sci Rep; 2017 Apr; 7():46458. PubMed ID: 28422172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between anthropometric parameters and measurements of liver stiffness by transient elastography.
    Wong GL; Chan HL; Choi PC; Chan AW; Lo AO; Chim AM; Wong VW
    Clin Gastroenterol Hepatol; 2013 Mar; 11(3):295-302.e1-3. PubMed ID: 23022698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver stiffness in nonalcoholic fatty liver disease: A comparison of supersonic shear imaging, FibroScan, and ARFI with liver biopsy.
    Cassinotto C; Boursier J; de Lédinghen V; Lebigot J; Lapuyade B; Cales P; Hiriart JB; Michalak S; Bail BL; Cartier V; Mouries A; Oberti F; Fouchard-Hubert I; Vergniol J; Aubé C
    Hepatology; 2016 Jun; 63(6):1817-27. PubMed ID: 26659452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transient elastography in healthy subjects and factors influencing liver stiffness in non-alcoholic fatty liver disease: An Italian community-based population study.
    Conti F; Vukotic R; Foschi FG; Domenicali M; Giacomoni P; Savini S; Lanzi A; Dall'Aglio AC; Saini G; Matroroberto M; Bernardi M; Stefanini GF; Andreone P
    Dig Liver Dis; 2016 Nov; 48(11):1357-1363. PubMed ID: 27522549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and severity of nonalcoholic fatty liver disease by transient elastography: Genetic and metabolic risk factors in a general population.
    Petta S; Di Marco V; Pipitone RM; Grimaudo S; Buscemi C; Craxì A; Buscemi S
    Liver Int; 2018 Nov; 38(11):2060-2068. PubMed ID: 29577560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of controlled attenuation parameter and liver stiffness measurement for detecting increased arterial stiffness in asymptomatic populations in China.
    Yu XY; Song XX; Tong YL; Wu LY; Song ZY
    Medicine (Baltimore); 2020 Nov; 99(48):e23360. PubMed ID: 33235107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Application of Liver Stiffness Measurement in Residents Without Overt Liver Diseases Through a Community-Based Screening Program.
    Cheng PN; Chiu YC; Chiu HC; Chien SC
    Medicine (Baltimore); 2016 Mar; 95(12):e3193. PubMed ID: 27015215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High Prevalence of Advanced Liver Fibrosis Assessed by Transient Elastography Among U.S. Adults With Type 2 Diabetes.
    Ciardullo S; Monti T; Perseghin G
    Diabetes Care; 2021 Feb; 44(2):519-525. PubMed ID: 33303638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver steatosis and nonalcoholic fatty liver disease with fibrosis are predictors of frailty in people living with HIV.
    Milic J; Menozzi V; Schepis F; Malagoli A; Besutti G; Franconi I; Raimondi A; Carli F; Mussini C; Sebastiani G; Guaraldi G
    AIDS; 2020 Nov; 34(13):1915-1921. PubMed ID: 33009010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Higher liver stiffness scores are associated with early kidney dysfunction in patients with histologically proven non-cirrhotic NAFLD.
    Sun DQ; Ye FZ; Kani HT; Yang JR; Zheng KI; Zhang HY; Targher G; Byrne CD; Chen YP; Yuan WJ; Yilmaz Y; Zheng MH
    Diabetes Metab; 2020 Sep; 46(4):288-295. PubMed ID: 31786360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of transient elastography (TE) and factors associated with discordance in non-alcoholic fatty liver disease.
    Mahadeva S; Mahfudz AS; Vijayanathan A; Goh KL; Kulenthran A; Cheah PL
    J Dig Dis; 2013 Nov; 14(11):604-10. PubMed ID: 23859493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of fetuin B with markers of liver fibrosis in nonalcoholic fatty liver disease.
    Ebert T; Linder N; Schaudinn A; Busse H; Berger J; Lichtinghagen R; Keim V; Wiegand J; Karlas T
    Endocrine; 2017 Nov; 58(2):246-252. PubMed ID: 28914407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with significant liver steatosis and fibrosis as assessed by transient elastography in patients with one or more components of the metabolic syndrome.
    Mikolasevic I; Milic S; Orlic L; Stimac D; Franjic N; Targher G
    J Diabetes Complications; 2016; 30(7):1347-53. PubMed ID: 27324703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. When the liver gets stiff, the tough get moving.
    Nguyen TH; Wardell R; Chitturi S; Teoh N; Farrell G
    J Gastroenterol Hepatol; 2020 Jun; 35(6):953-959. PubMed ID: 31867782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.